[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Dominates Global Generic Injectables Market, Says IMARC Group in Its New Report Available at MarketPublishers.com

30 Nov 2017 • by Natalie Aster

LONDON – Between 2009 and 2016, the worldwide market for generic injectables increased at a 9% CAGR and amounted to USD 43 billion in value terms. Due to numerous advancements provided by generic injectables, governments in different countries are supporting their production. Other important market growth drivers comprise patent expiry of a number of blockbuster drugs, increasing drug shortages (especially in the USA), expanding prevalence of chronic and lifestyle diseases, and rapidly aging population, amidst others.

At present, North America accounts for the biggest chunk of the overall market for generic injectables. The region’s market share is over 50%.

Some of the prominent companies operating in the global generic injectables market include Fresenius Kabi, Baxter, Hospira (Pfizer), Hikma, Sagent, Sandoz (Novartis), Sanofi.

New research report “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” elaborated by IMARC Group offers a profound analysis of the world’s generic injectables market segmenting it on the basis of distribution channels, therapeutic areas and regions.

This report provides in-depth insights into the generic injectables market landscape and dynamics, examines the main factors stimulating and hampering the market growth, sheds light on the prevailing development trends. It contains a snapshot of the most recent industry developments, SWOT analysis, value chain analysis, Porter’s five forces analysis and trustworthy updated statistics. Besides, this study also gives valuable recommendations for setting up a generic injectables manufacturing plant. Moreover, it touches upon such important aspects as project costs, processing and manufacturing requirements, project economics and funding, expected returns on investments, etc. in addition, this publication reviews the emerging generic injectables market growth challenges and opportunities, and contains future forecasts up to 2022.

A full collection of the publisher’s research reports is available in the IMARC Group online catalogue at MarketPubishers.com.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]





Analytics & News

Weekly Digest